NDA 021074 · Solventum
Avagard
Alcohol, Chlorhexidine Gluconate · Topical
Last checked: Nov 20, 2026Latest source record: Sep 6, 2017 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2001
Jun 7, 2001
Approved uses
1
Original approval plus efficacy supplements
Registered trials
6,382
1,281 Phase 3, 471 recruiting
FAERS reports
5
4 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Apr 22, 2026.
Uses surgical hand antiseptic: significantly reduces the number of micro-organisms on the hands and forearms prior to surgery or patient care healthcare personnel hand antiseptic: hand rub to help reduce bacteria that potentially can cause disease recommended for repeated use
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
1 products under this application
- AVAGARD · ALCOHOL 61%; CHLORHEXIDINE GLUCONATE 1% · SOLUTION, TOPICAL · Over-the-counter
Clinical trials
Interventional ClinicalTrials.gov studies with "Alcohol" as an intervention, any sponsor and status, largest first.
- Efficacy and Safety of Adding Clopidogrel to Aspirin or Use of Metoprolol in Myocardial InfarctionPivotal-lookingCompleted
University of OxfordAcademic, hospital or other
NCT00222573 · 46,000 participants · Start Jul 1999
Drug: clopidogrel and metoprolol · For: Acute Myocardial Infarction
Sites: Beijing, China; Oxford, United Kingdom
Vanderbilt University Medical CenterAcademic, hospital or other
NCT02726620 · 22,435 participants · Start Jan 5, 2017 · Primary completion Dec 31, 2017
Drug: Propofol; Sevoflurane and 32 more · For: Hypotension
Sites: Nashville, Tennessee
- Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk AssessmentPivotal-lookingCompleted
University of VigoAcademic, hospital or other
NCT00741585 · 21,983 participants · Start Sep 1, 2008 · Primary completion Jun 30, 2018
Drug: Any antihypertensive medication alone or in combination; Any antihypertensive medication alone or in combination · For: Essential Hypertension; Cardiovascular Disease; Stroke and 1 more
Sites: Friol, Spain; A Estrada, Spain; Baiona, Spain · 20 sites in all
- The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac SurgeryPivotal-lookingRecruiting
University of California, San FranciscoAcademic, hospital or other
NCT06802224 · 18,000 participants (planned) · Start Apr 1, 2025 · Primary completion Jul 2028
Drug: Norepinephrine; Phenylephrine · For: Anesthesia; Surgery With General Anesthesia; Noncardiac Surgery and 4 more
Sites: San Francisco, California; College Park, Maryland; Ann Arbor, Michigan · 10 sites in all
Centro Neurológico de Pesquisa e Reabiitação, BrazilAcademic, hospital or other
NCT03147092 · 15,000 participants (planned) · Start Feb 1, 2018 · Primary completion Jun 30, 2020
Drug: Captopril 25Mg, Hydrochlorothiazide 25Mg Oral Tablet,; Atenolol and 2 more · For: Hypertension; Blood Pressure
GlaxoSmithKlineGSK (GSK)
NCT01475721 · 11,751 participants · Start Nov 18, 2011 · Primary completion Jun 23, 2015
Drug: ADVAIR 100/50mcg; ADVAIR 250/50mcg and 4 more · For: Asthma
Sites: Athens, Alabama; Birmingham, Alabama; Florence, Alabama · 808 sites in all
- A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241)Pivotal-lookingCompleted
Organon and CoIndustry
NCT01471340 · 11,744 participants · Start Jan 9, 2012 · Primary completion Nov 30, 2016
Drug: Mometasone Furoate/Formoterol MDI 100/5 mcg; Mometasone Furoate/Formoterol MDI 200/5 mcg and 4 more · For: Asthma
- Action to Control Cardiovascular Risk in Diabetes (ACCORD)Pivotal-lookingCompleted
National Heart, Lung, and Blood Institute (NHLBI)NIH
NCT00000620 · 10,251 participants · Start Sep 1999 · Primary completion Jun 2009
Drug: Anti-hyperglycemic Agents; Anti-hypertensive Agents and 1 more · For: Atherosclerosis; Cardiovascular Diseases; Hypercholesterolemia and 4 more
Sites: Minneapolis, Minnesota; New York, New York; Winston-Salem, North Carolina · 7 sites in all
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- rash2
- rash pruritic2
- burns second degree1
- burns third degree1
- eye irritation1
- urticaria1
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2020 | 1 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Cancer risk based on alcohol consumption levels: a comprehensive systematic review and meta-analysis.
Jun S, Park H, Kim UJ, et al. · Epidemiol Health 2023 · Meta-Analysis, Systematic Review
- Alcohol-related peripheral neuropathy: a systematic review and meta-analysis.
Julian T, Glascow N, Syeed R, et al. · J Neurol 2019 · Meta-Analysis, Systematic Review
- Alcohol Intake and Risk of Hypertension: A Systematic Review and Dose-Response Meta-Analysis of Nonexperimental Cohort Studies.
Cecchini M, Filippini T, Whelton PK, et al. · Hypertension 2024 · Systematic Review, Meta-Analysis
- The effect of alcohol on subsequent sleep in healthy adults: A systematic review and meta-analysis.
Gardiner C, Weakley J, Burke LM, et al. · Sleep Med Rev 2025 · Systematic Review, Meta-Analysis
- Evaluation of the course and treatment of Alcohol Withdrawal Syndrome with the Clinical Institute Withdrawal Assessment for Alcohol - Revised: A systematic review-based meta-analysis.
Pribék IK, Kovács I, Kádár BK, et al. · Drug Alcohol Depend 2021 · Meta-Analysis, Research Support, Non-U.S. Gov't
- The Relationship Between Alcohol Consumption, BMI, and Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis.
Llamosas-Falcón L, Rehm J, Bright S, et al. · Diabetes Care 2023 · Systematic Review, Meta-Analysis
Sponsor: Solventum
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.